News
Tag: Company Updates
-
Achieve Life Sciences Becomes AchieveRx, The Quit Company, and Will Trade Under the Ticker QUIT
New name and ticker reflect a mission-driven company with one purpose: developing medicine for people who want to quit smoking or vaping. If approved, cytisinicline would be the first new medicine approved by the FDA for quitting smoking in 20 years, and potentially the first ever for quitting vaping. SEATTLE and VANCOUVER, British Columbia, November…
-
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
Brings 15 years of pharma launch, health system, and direct-to-patient engagement experience as Achieve prepares for potential commercialization of cytisinicline. SEATTLE and VANCOUVER, British Columbia, October 7, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline…
-
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
Brings public company CFO experience across commercial pharma and business development as Achieve prepares for potential commercialization of cytisinicline. SEATTLE and VANCOUVER, British Columbia, October 1, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as…
-
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality
Veteran U.S.-based CMC, supply chain, and quality leaders join Achieve as the Company continues the transition of cytisinicline finished product manufacturing to the United States. SEATTLE and VANCOUVER, British Columbia, August 3, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global…
-
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
Appointments Add Deep Biopharmaceutical Commercial Strategy, Clinical and Finance Expertise as Company Advances Toward Potential Cytisinicline Approval and Launch. SEATTLE and VANCOUVER, British Columbia, June 2, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (“Achieve” or the “Company”) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as…